ACHIEVE LIFE SCIENCES, INC. — Director's Dealing 2009

Jul 10, 2009

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ONCOGENEX PHARMACEUTICALS, INC. (OGXI)
CIK: 0000949858
Period of Report: 2009-07-10

Reporting Person: Cormack Scott Daniel (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2009-07-10	Common Stock	M	871	$3.889	Acquired	1886	Indirect
2009-07-10	Common Stock	G	871	$0.00	Disposed	1015	Indirect
2009-07-10	Common Stock	G	871	$0.00	Acquired	25680	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2009-07-09	stock option (right to buy)	$3.889	M	871	Disposed	2009-08-01	Common Stock (871)	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	6306	Direct

Footnotes

F1: Scott D. Cormack and his spouse are the trustees and beneficiaries of the Trycor Investment Trust No. 1